These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20075547)

  • 1. An anesthetic in use with bronchodilator inhaler: a fact less known.
    Kummar P; Korula G; Ninan S; Karthikeyan C
    Ann Card Anaesth; 2010; 13(1):77-8. PubMed ID: 20075547
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress of research on pressurized metered dose inhalers].
    Zhou X
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
    Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming dose-counting mechanisms on metered-dose inhalers for urgent treatment in the operating room.
    Templeton LB; Galyon SW; Smith TE
    Anesth Analg; 2009 Nov; 109(5):1709-10. PubMed ID: 19843820
    [No Abstract]   [Full Text] [Related]  

  • 5. A switch to eco-friendly inhalers.
    Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):2. PubMed ID: 19370797
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL; Noonan MJ; Weinstein SF; Chervinsky P; Scott CA; Herje NE; Wu W; Crim C
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFC Phase-Out and the Chiesi Solution.
    Huchon G; Fabbri LM
    Respiration; 2005; 72 Suppl 1():1-2. PubMed ID: 15915005
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
    Lumry WR; Conway MM; LaForce CF; Pearlman DS; Scott CA; Herje NE; Wu WW; Crim C
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic equivalence study of CFC-free and CFC-containing procaterol hydrochloride metered-dose inhalers.
    Kawai M; Nakashima M; Takaori S; Nakamura Y; Akamatsu K; Nakashima M; Miyamoto T
    Methods Find Exp Clin Pharmacol; 2005 Oct; 27(8):555-8. PubMed ID: 16273135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HFA inhalers.
    Koninck JC; Magro P; Khanjari F; Lemarié E; Diot P
    Pediatr Pulmonol Suppl; 2004; 26():23-5. PubMed ID: 15029583
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants.
    Hendeles L; Colice GL; Meyer RJ
    N Engl J Med; 2007 Mar; 356(13):1344-51. PubMed ID: 17392304
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydrofluoroalkane as a propellant for pressurized metered-dose inhalers: history, pulmonary deposition, pharmacokinetics, efficacy and safety].
    Ibiapina CC; Cruz AA; Camargos PA
    J Pediatr (Rio J); 2004; 80(6):441-6. PubMed ID: 15622419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in studies of pressurized metered dose formulations containing hydrofluoroalkane propellants].
    Liao YH; Zeng XM
    Yao Xue Xue Bao; 2006 Mar; 41(3):197-202. PubMed ID: 16758987
    [No Abstract]   [Full Text] [Related]  

  • 17. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
    Braunstein G; Sharma R
    Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing aerosol delivery by pressurized metered-dose inhalers.
    Rubin BK; Fink JB
    Respir Care; 2005 Sep; 50(9):1191-200. PubMed ID: 16122402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propellant-based inhalers for the non-invasive delivery of genes via oral inhalation.
    Conti DS; Bharatwaj B; Brewer D; da Rocha SR
    J Control Release; 2012 Feb; 157(3):406-17. PubMed ID: 21982899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability of two hydrofluoroalkane formulations of formoterol fumarate both delivered by pressurised metered dose inhaler.
    Po CJ; Chandran SS; Syed N; Naidu KR; Rathod M; Sule A; Lulla A; Purandare S
    Arzneimittelforschung; 2010; 60(2):81-6. PubMed ID: 20329656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.